129 related articles for article (PubMed ID: 36868772)
21. Quantification of cellular poly(ADP-ribosyl)ation by stable isotope dilution mass spectrometry reveals tissue- and drug-dependent stress response dynamics.
Martello R; Mangerich A; Sass S; Dedon PC; Bürkle A
ACS Chem Biol; 2013 Jul; 8(7):1567-75. PubMed ID: 23631432
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
23. BTH-8, a novel poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor, causes DNA double-strand breaks and exhibits anticancer activities in vitro and in vivo.
Guo C; Zhang F; Wu X; Yu X; Wu X; Shi D; Wang L
Int J Biol Macromol; 2020 May; 150():238-245. PubMed ID: 32057845
[TBL] [Abstract][Full Text] [Related]
24. PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia.
Herriott A; Tudhope SJ; Junge G; Rodrigues N; Patterson MJ; Woodhouse L; Lunec J; Hunter JE; Mulligan EA; Cole M; Allinson LM; Wallis JP; Marshall S; Wang E; Curtin NJ; Willmore E
Oncotarget; 2015 Dec; 6(41):43978-91. PubMed ID: 26539646
[TBL] [Abstract][Full Text] [Related]
25. Impedance-Based Nanoporous Anodized Alumina/ITO Platforms for Label-Free Biosensors.
Devarakonda S; Ganapathysubramanian B; Shrotriya P
ACS Appl Mater Interfaces; 2022 Jan; 14(1):150-158. PubMed ID: 34937345
[TBL] [Abstract][Full Text] [Related]
26. Poly (ADP-ribose) polymerase activation and circulatory shock.
Szabó C
Novartis Found Symp; 2007; 280():92-103; discussion 103-7, 160-4. PubMed ID: 17380790
[TBL] [Abstract][Full Text] [Related]
27. Poly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.
Gottipati P; Vischioni B; Schultz N; Solomons J; Bryant HE; Djureinovic T; Issaeva N; Sleeth K; Sharma RA; Helleday T
Cancer Res; 2010 Jul; 70(13):5389-98. PubMed ID: 20551068
[TBL] [Abstract][Full Text] [Related]
28. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
Kim IK; Stegeman RA; Brosey CA; Ellenberger T
J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
[TBL] [Abstract][Full Text] [Related]
29. p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.
Dutto I; Sukhanova M; Tillhon M; Cazzalini O; Stivala LA; Scovassi AI; Lavrik O; Prosperi E
PLoS One; 2016; 11(1):e0146031. PubMed ID: 26730949
[TBL] [Abstract][Full Text] [Related]
30. Label-free electrochemical immunosensor for picomolar detection of the cervical cancer biomarker MCM5.
Barhoum A; J Forster R
Anal Chim Acta; 2022 Sep; 1225():340226. PubMed ID: 36038236
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials.
Zaremba T; Thomas H; Cole M; Plummer ER; Curtin NJ
Cancer Chemother Pharmacol; 2010 Sep; 66(4):807-12. PubMed ID: 20490796
[TBL] [Abstract][Full Text] [Related]
32. Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer.
Parkes EE; Kennedy RD
Oncologist; 2016 May; 21(5):586-93. PubMed ID: 27022037
[TBL] [Abstract][Full Text] [Related]
33. AFM, CLSM and EIS characterization of the immobilization of antibodies on indium-tin oxide electrode and their capture of Legionella pneumophila.
Souiri M; Blel N; Sboui D; Mhamdi L; Epalle T; Mzoughi R; Riffard S; Othmane A
Talanta; 2014 Jan; 118():224-30. PubMed ID: 24274292
[TBL] [Abstract][Full Text] [Related]
34. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.
Luo X; Kraus WL
Genes Dev; 2012 Mar; 26(5):417-32. PubMed ID: 22391446
[TBL] [Abstract][Full Text] [Related]
35. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
Goebel DJ; Winkler BS
J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
[TBL] [Abstract][Full Text] [Related]
36. Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.
Perina D; Mikoč A; Ahel J; Ćetković H; Žaja R; Ahel I
DNA Repair (Amst); 2014 Nov; 23():4-16. PubMed ID: 24865146
[TBL] [Abstract][Full Text] [Related]
37. PARP-1 inhibition induces a late increase in the level of reactive oxygen species in cells after ionizing radiation.
Cieślar-Pobuda A; Saenko Y; Rzeszowska-Wolny J
Mutat Res; 2012 Apr; 732(1-2):9-15. PubMed ID: 22321899
[TBL] [Abstract][Full Text] [Related]
38. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
39. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
40. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.
Harrision D; Gravells P; Thompson R; Bryant HE
Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
